Skip to main content

Advertisement

SpringerLink
Log in

MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study

  • Brief Report
  • Published:
Virchows Archiv Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Laco J, Sieglová K, Vošmiková H, Dundr P, Němejcová K, Michálek J, Čelakovský P, Chrobok V, Mottl R, Mottlová A, Tuček L, Slezák R, Chmelařová M, Sirák I, Vošmik M, Ryška A (2015) The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis. Virchows Arch 467(4):405–415. https://doi.org/10.1007/s00428-015-1812-x

    Article  PubMed  CAS  Google Scholar 

  2. Laco J, Vosmikova H, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Nekvindova J, Vosmik M, Cermakova E, Ryska A (2011) The role of high risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases. Virchows Arch 458(2):179–187. https://doi.org/10.1007/s00428-010-1037-y

    Article  PubMed  CAS  Google Scholar 

  3. Laco J, Nekvindova J, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Vosmikova H, Vosmik M, Neskudlova T, Cermakova E, Hacova M, Ryska A (2012) Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16INK4a expression, and HPV status. Neoplasma 59(04):398–408. https://doi.org/10.4149/neo_2012_052

    Article  PubMed  CAS  Google Scholar 

  4. Laco J, Kovaříková H, Chmelařová M, Vošmiková H, Sieglová K, Bubancová I, Dundr P, Němejcová K, Michálek J, Čelakovský P, Mottl R, Sirák I, Vošmik M, Marek I, Geryk T, Mejzlík J, Šatanková J, Ryška A (2018) Analysis of DNA methylation and microRNA expression in NUT (nuclear protein in testis) midline carcinoma of the sinonasal tract: a clinicopathological, immunohistochemical and molecular genetic study. Neoplasma 65:101–111. https://doi.org/10.4149/neo_2018_161122N581

    Article  Google Scholar 

  5. Agaimy A, Koch M, Lell M, Semrau S, Dudek W, Wachter DL, Knöll A, Iro H, Haller F, Hartmann A (2014) SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. Am J Surg Pathol 38(9):1274–1281. https://doi.org/10.1097/PAS.0000000000000236

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bishop JA, Antonescu CR, Westra WH (2014) SMARCB1 (INI-1)-deficient carcinoma of the sinonasal tract. Am J Surg Pathol 38(9):1282–1289. https://doi.org/10.1097/PAS.0000000000000285

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bell D, Hanna EY, Agaimy A, Weissferdt A (2015) Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Arch 467(6):649–656. https://doi.org/10.1007/s00428-015-1853-1

    Article  PubMed  CAS  Google Scholar 

  8. Allison DB, Bishop JA, Ali SZ (2016) Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: a potential diagnostic pitfall. Diagn Cytopathol 44(8):700–703. https://doi.org/10.1002/dc.23503

    Article  PubMed  Google Scholar 

  9. Wasserman JK, Dickson BC, Perez-Ordonez B, de Almeida JR, Irish JC, Weinreb I (2017) INI1 (SMARCB1)-deficient sinonasal carcinoma: a clinicopathologic report of 2 cases. Head Neck Pathol 11(2):256–261. https://doi.org/10.1007/s12105-016-0752-3

    Article  PubMed  Google Scholar 

  10. Agaimy A, Hartmann A, Antonescu CR, Chiosea SI, El-Mofty SK, Geddert H, Iro H, Lewis JS Jr, Märkl B, Mills SE, Riener MO, Robertson T, Sandison A, Semrau S, Simpson RH, Stelow E, Westra WH, Bishop JA (2017) SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity. Am J Surg Pathol 41(4):458–471. https://doi.org/10.1097/PAS.0000000000000797

    Article  PubMed  PubMed Central  Google Scholar 

  11. Laco J, Chmelařová M, Vošmiková H, Sieglová K, Bubancová I, Dundr P, Němejcová K, Michálek J, Čelakovský P, Mottl R, Sirák I, Vošmik M, Ryška A (2017) SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: a clinicopathological, immunohistochemical and molecular genetic study of a recently described entity. Pathol Res Pract 213(2):133–142. https://doi.org/10.1016/j.prp.2016.10.012

    Article  PubMed  CAS  Google Scholar 

  12. Chmelařová M, Sirák I, Mžik M, Sieglová K, Vošmiková H, Dundr P, Němejcová K, Michálek J, Vošmik M, Palička V, Laco J (2016) Importance of tumour suppressor gene methylation in sinonasal carcinomas. Folia Biol (Praha) 62(3):110–119

    Google Scholar 

  13. Kovarikova H, Bubancova I, Laco J, Sieglova K, Vosmikova H, Dundr P, Nemejcova K, Michalek J, Vosmik M, Palicka V, Chmelarova M (2017) Deregulation of selected microRNAs in sinonasal carcinoma: value of miR-21 as prognostic biomarker in sinonasal squamous cell carcinoma. Head Neck 39(12):2528–2536. https://doi.org/10.1002/hed.24930

    Article  PubMed  Google Scholar 

  14. Jamali Z, Asl Aminabadi N, Attaran R, Pournagiazar F, Ghertasi Oskouei S, Ahmadpour F (2015) MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 51(4):321–331. https://doi.org/10.1016/j.oraloncology.2015.01.008

    Article  PubMed  CAS  Google Scholar 

  15. Sredni ST, Bonaldo Mde F, Costa FF, Huang CC, Hamm CA, Rajaram V, Tomita T, Goldman S, Bischof JM, Soares MB (2010) Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst 26(3):279–283. https://doi.org/10.1007/s00381-009-1028-y

    Article  PubMed  Google Scholar 

  16. Grupenmacher AT, Halpern AL, Bonaldo Mde F, Huang CC, Hamm CA, de Andrade A, Tomita T, Sredni ST (2013) Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK). Childs Nerv Syst 29(11):1977–1983. https://doi.org/10.1007/s00381-013-2268-4

    Article  PubMed  Google Scholar 

  17. Kohashi K, Yamamoto H, Kumagai R, Yamada Y, Hotokebuchi Y, Taguchi T, Iwamoto Y, Oda Y (2014) Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulated SMARCB1 mRNA expression. Mod Pathol 27(6):832–839. https://doi.org/10.1038/modpathol.2013.213

    Article  PubMed  CAS  Google Scholar 

  18. Sápi Z, Papp G, Szendröi PZ, Plótár V, Krausz T, Fletcher CD (2016) Epigenetic regulation of SMARCB1 by miR-2016, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas. Genes Chromosomes Cancer 55(10):786–802. https://doi.org/10.1002/gcc.22379

    Article  PubMed  CAS  Google Scholar 

  19. Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16(3):203–222. https://doi.org/10.1038/nrd.2016.246

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

The study was supported by the Charles University Research Development Program PROGRES Q40/11, by the project BBMRI-CZ LM2015089 (Ministry of Education, Youth and Sports; Czech Republic), by the European Regional Development Fund-Project BBMRI-CZ.: Biobank network—a versatile platform for the research of the etiopathogenesis of diseases, no. EF16 013/0001674 (Ministry of Education, Youth and Sports; Czech Republic), and by the conceptual development of research organization MH CZ-DRO (FNHK) 00179906 (Ministry of Health, Czech Republic). The funding sources had no influence on the study design, on collection, analysis, and interpretation of data, on writing of the report, and on decision to submit the article for publication.

Author information

Authors and Affiliations

  1. The Fingerland Department of Pathology, Faculty of Medicine and University Hospital, Charles University, Sokolska 581, 500 05, Hradec Kralove, Czech Republic

    Jan Laco, Hana Vošmiková, Kateřina Sieglová & Aleš Ryška

  2. Institute for Clinical Biochemistry and Diagnostics, Faculty of Medicine and University Hospital, Charles University, Hradec Kralove, Czech Republic

    Helena Kovaříková, Marcela Chmelařová & Ivana Baranová

  3. Department of Pathology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic

    Pavel Dundr & Kristýna Němejcová

  4. Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry and University Hospital, Palacky University, Olomouc, Czech Republic

    Jaroslav Michálek

  5. Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine and University Hospital, Charles University, Hradec Kralove, Czech Republic

    Jana Šatanková

  6. Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital, Charles University, Hradec Kralove, Czech Republic

    Milan Vošmik

Authors
  1. Jan Laco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helena Kovaříková
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcela Chmelařová
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hana Vošmiková
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kateřina Sieglová
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ivana Baranová
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Pavel Dundr
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kristýna Němejcová
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jaroslav Michálek
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jana Šatanková
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Milan Vošmik
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Aleš Ryška
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Laco.

Ethics declarations

The experiments carried out in this study comply with the current laws of the Czech Republic. The study was approved by the Ethics Committee, University Hospital, Hradec Kralove, Czech Republic (no. 201602 I118P). As the research did not involve human participants and/or animals, neither informed consent nor statement of welfare of animals was needed.

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

ESM 1

(DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laco, J., Kovaříková, H., Chmelařová, M. et al. MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study. Virchows Arch 472, 871–875 (2018). https://doi.org/10.1007/s00428-018-2293-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-018-2293-5

Search

Navigation